Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106M Sell
892,400
-615,066
-41% -$71M 1.36% 22
2026
Q1
$182M Sell
1,507,466
-90,740
-6% -$11.9M 1.96% 20
2025
Q4
$217M Sell
1,598,206
-38,890
-2% -$5.59M 2.05% 16
2025
Q3
$241M Buy
1,637,096
+36,992
+2% +$5.13M 2.37% 13
2025
Q2
$208M Buy
1,600,104
+11,557
+0.7% +$1.4M 2.71% 11
2025
Q1
$189M Sell
1,588,547
-495,017
-24% -$61.3M 2.62% 15
2024
Q4
$239M Buy
2,083,564
+25,129
+1% +$3.18M 3.23% 10
2024
Q3
$276M Buy
2,058,435
+34,812
+2% +$4.66M 3.78% 7
2024
Q2
$277M Sell
2,023,623
-2,417
-0.1% -$329K 4.19% 6
2024
Q1
$262M Sell
2,026,040
-16,124
-0.8% -$1.95M 3.92% 9
2023
Q4
$235M Sell
2,042,164
-89,915
-4% -$8.97M 3.86% 7
2023
Q3
$194M Buy
2,132,079
+99,793
+5% +$10.3M 3.49% 10
2023
Q2
$230M Sell
2,032,286
-33,471
-2% -$3.54M 4.67% 7
2023
Q1
$217M Buy
+2,065,757
New +$216M 4.84% 7

Other funds holding XYL

ABN AMRO Bank's XYL Position: Q2 2026 in Review

ABN AMRO Bank reduced its Xylem (XYL) stake by 41% in Q2 2026, selling an estimated $71M and leaving 892,400 shares worth $106M. The position accounts for 1.36% of the portfolio, ranked #22.

ABN AMRO Bank first reported a position in XYL in Q1 2023 and has held it in 14 quarters since. The position peaked at $277M in Q2 2024. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • ABN AMRO Bank held 892,400 shares of Xylem worth $106M as of Q2 2026.
  • ABN AMRO Bank sold 615,066 Xylem shares in Q2 2026, an estimated $71M.
  • Xylem made up 1.36% of ABN AMRO Bank's portfolio in Q2 2026, its #22 holding.
  • ABN AMRO Bank first reported a position in Xylem in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Bank's Xylem position peaked at $277M in Q2 2024.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.